The New York creator calls it "Reta" and fans are split between support and missing her old look. Retatrutide is still in trials and not FDA approved.
Recap by typeshit. Full story at theblast.
11:54
Ryan Sims of Optimal Health Project gives a follow-up on how things have gone in the months since his 35-pound loss on the experimental drug.
The Tico Times reports Costa Rica's public system is considering offering GLP-1 weight loss drugs to patients. Tap through for where the discussion stands.
Fiscal.ai posted a chart comparing Lilly and Novo Nordisk and says Lilly is pulling ahead in the obesity drug market. Only the chart is shared, with no other detail.
A short clip of Rosie O'Donnell discussing the tirzepatide drug Mounjaro. Few details are given beyond the title.
After so-called Ozempic face and Ozempic hair loss, the post says another digestive symptom is getting attention and may point to something more than discomfort.
A new episode of the Annals of Internal Medicine podcast looks at tirzepatide in type 2 diabetes treatment. Listen through for the full discussion.
Loading…